MARCH2, a T cell specific factor that restricts HIV-1 infection

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Membrane-associated RING-CH (MARCH) 2 is an E3 ubiquitin ligase regulating cell surface proteins.
• MARCH proteins, including MARCH1, 2, and 8, inhibit HIV-1 by preventing envelope glycoprotein incorporation into virions.
• The precise mechanism of MARCH protein-mediated HIV-1 restriction requires further elucidation.

Purpose of the Study:

• To identify key features of human MARCH2 essential for its antiretroviral function.
• To investigate the mechanism by which MARCH2 restricts HIV-1 infection.
• To determine the cellular context and transmission routes affected by MARCH2.

Main Methods:

• Amino acid and domain mapping of human MARCH2.
• Analysis of MARCH2 localization within nascent virions.
• Assessment of MARCH2's impact on HIV-1 infectivity and entry.
• Evaluation of MARCH2's role in primary CD4+ T cells and cell-to-cell transmission.

Main Results:

• A specific amino acid in human MARCH2, absent in mouse MARCH2, is critical for antiretroviral activity.
• Domains of human MARCH2 essential for HIV-1 envelope glycoprotein binding and restriction were identified.
• MARCH2 was found within nascent virions, reducing infectivity by blocking virus entry independently of its RING-CH domain.
• MARCH2 functions as an HIV-1 restriction factor specifically in primary CD4+ T cells, inhibiting cell-to-cell transmission.

Conclusions:

• Human MARCH2 possesses a unique antiretroviral mechanism involving intracellular localization and entry inhibition.
• Specific molecular determinants within MARCH2 dictate its interaction with HIV-1 and its restriction capability.
• MARCH2's role as a restriction factor in CD4+ T cells highlights its importance in controlling HIV-1 spread and has implications for other MARCH proteins and viral targets.